(2000), Horm Res 53(Suppl 3), PubMed 10971106 Statistics from preclinical literature AOD-9604 = modified fragment of hGH 177191 + N-terminal Tyr (sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe), molecular weight 1815.1 Da Developed at Metabolic Pharmaceuticals (Australia) based on the work of professor Frank Ng (Monash University) in the 1990s Standard experimental dose in obesity clinical trials: 1 mg/day subcutaneously (Phase 2b, Heffernan et al.) Mechanism: stimulation of 3-adrenergic receptors in adipose tissue, increased lipolysis and fatty acid oxidation without activation of the hGH receptor (no IGF-1 increase) Phase 2b clinical trial (2007, 300 patients): weight reduction ~2.8 kg vs placebo over 12 weeks FDA status: NDI rejection (2014) as a dietary supplement
Peptides are susceptible to variation in quality, sourcing, compounding errors, which may increase risk, therefore, this is why strongly recommend sourcing peptides for your own personal use via a clinician/provider who can monitor your strategy and success
If you use another B12 injection kit (hopefully not cyano B12), aim for at least 1 mg of B12 per shot, which is plenty
This treatment works by blocking the release of the chemical responsible for muscle contractions, allowing those muscles to relax and reducing the appearance of wrinkles
Nature Reviews Endocrinology, 16(3), 135-146
These compounds improve the availability of energy and assist in balancing mineral disorders
